selegiline has been researched along with n-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morón, J; Pastó, M; Pérez, V; Unzeta, M | 1 |
| Pastó, M; Pérez, V; Unzeta, M | 1 |
| Bellik, L; Marco, JI; Romera, M; Sanz, E; Unzeta, M | 1 |
3 other study(ies) available for selegiline and n-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine
| Article | Year |
|---|---|
Neuroprotective aspects of a novel MAO-B inhibitor PF9601N.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Indoles; Male; Methylamines; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinsonian Disorders; Selegiline | 2000 |
Involvement of Ca2+ in dopamine release in striatal rat slices by PF9601N and L-deprenyl.
Topics: Animals; Calcium; Corpus Striatum; Dopamine; Indoles; Methylamines; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selegiline | 2000 |
Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease.
Topics: Animals; Antioxidants; Antiparkinson Agents; Brain; Brain Chemistry; Cell Line, Tumor; Dopamine; Dose-Response Relationship, Drug; Humans; Indoles; Melanins; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Selegiline; Tryptamines | 2004 |